Search

everythinglearnresearchcommunity

for

Search:↓

PCOS diagnosis and treatment should consider race and ethnicity for accuracy.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Most skin changes during pregnancy are harmless and moles don't significantly change, but many women experience pigmentation changes due to hormones and sun exposure.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

No significant vocal differences were found in people with PCOS compared to others.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Women with PCOS have lower quality of life, especially in mental health and energy, and managing weight can help improve it.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

About 5% of Thai university girls aged 17-19 have polycystic ovary syndrome, with moderate acne being a strong risk factor.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

Bacterial vaginosis is not linked to skin disorders in these patients.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.